Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Evens

Showing results (41-50 of 253) with videos related to

Pageof 26
Sort By:
Current Treatment Options in Oncology|June 22, 2005
Motexafin gadolinium induces oxidative stress and apoptosis in hematologic malignanciesAndrew M Evens, Lakshmi Balasubramanian, Leo I Gordon
Journal of the Massachusetts Dental Society|July 15, 2015
A Clinico-Pathologic Correlation. Burkitt's lymphoma)Ray English, Alireza Ashrafi, Andrew M Evens, et al.
Current Hematologic Malignancy Reports|June 6, 2013
Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategiesZeina Al-Mansour, Beverly P Nelson, Andrew M Evens
Leukemia Research|July 6, 2004
The potential of arsenic trioxide in the treatment of malignant disease: past, present, and futureAndrew M Evens, Martin S Tallman, Ronald B Gartenhaus
Paediatric Anaesthesia|March 5, 2008
Life threatening cavopulmonary thrombus: resolution within 24 h with tissue plasminogen activatorIgnacio Malagon, Fabiola C M Evens, Mathias W Freund
Oncology (Williston Park, N.Y.)|December 18, 2008
Hodgkin lymphoma in older patients: an uncommon disease in need of studyAndrew M Evens, John W Sweetenham, Sandra J Horning
Cancer & Metabolism|October 12, 2022
Scaffold-mediated switching of lymphoma metabolism in cultureRachana Bhatt, Dashnamoorthy Ravi, Andrew M Evens, et al.
Blood|March 5, 2015
Lenalidomide in non-Hodgkin lymphoma: biological perspectives and therapeutic opportunitiesAthena Kritharis, Michael Coyle, Jaya Sharma, et al.
Current Treatment Options in Oncology|January 14, 2012
Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendationsDeepa Jagadeesh, Bruce A Woda, Jacqueline Draper, et al.
Tijdschrift Voor Kindergeneeskunde|June 1, 1983
[Neonatal hyperammonemia]J Jaeken, H Devlieger, M Evens, et al.
Pageof 26

Showing results (41-50 of 253) with videos related to

Sort By:
Pageof 26
Current Treatment Options in Oncology|June 22, 2005
Motexafin gadolinium induces oxidative stress and apoptosis in hematologic malignanciesAndrew M Evens, Lakshmi Balasubramanian, Leo I Gordon
Journal of the Massachusetts Dental Society|July 15, 2015
A Clinico-Pathologic Correlation. Burkitt's lymphoma)Ray English, Alireza Ashrafi, Andrew M Evens, et al.
Current Hematologic Malignancy Reports|June 6, 2013
Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategiesZeina Al-Mansour, Beverly P Nelson, Andrew M Evens
Leukemia Research|July 6, 2004
The potential of arsenic trioxide in the treatment of malignant disease: past, present, and futureAndrew M Evens, Martin S Tallman, Ronald B Gartenhaus
Paediatric Anaesthesia|March 5, 2008
Life threatening cavopulmonary thrombus: resolution within 24 h with tissue plasminogen activatorIgnacio Malagon, Fabiola C M Evens, Mathias W Freund
Oncology (Williston Park, N.Y.)|December 18, 2008
Hodgkin lymphoma in older patients: an uncommon disease in need of studyAndrew M Evens, John W Sweetenham, Sandra J Horning
Cancer & Metabolism|October 12, 2022
Scaffold-mediated switching of lymphoma metabolism in cultureRachana Bhatt, Dashnamoorthy Ravi, Andrew M Evens, et al.
Blood|March 5, 2015
Lenalidomide in non-Hodgkin lymphoma: biological perspectives and therapeutic opportunitiesAthena Kritharis, Michael Coyle, Jaya Sharma, et al.
Current Treatment Options in Oncology|January 14, 2012
Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendationsDeepa Jagadeesh, Bruce A Woda, Jacqueline Draper, et al.
Tijdschrift Voor Kindergeneeskunde|June 1, 1983
[Neonatal hyperammonemia]J Jaeken, H Devlieger, M Evens, et al.
Pageof 26